Decrease in opioid and intra-articular corticosteroid burden after intra-articular hyaluronic acid for knee osteoarthritis treatment.

Pain Manag

New Jersey Regenerative Institute, 197 Ridgedale Ave #210, Cedar Knolls, NJ 07927, USA; Clinical Professor Dept. of Physical Medicine & Rehabilitation, Rutgers School of Medicine - NJ Medical School Newark, NJ 07109, USA.

Published: November 2020

We studied changes in opioid prescriptions and corticosteroid injection use for knee osteoarthritis patients before and after intra-articular hyaluronic acid (HA) use and opioid prescriptions before and after knee arthroplasty (KA).  A total of 1,017,578 knee osteoarthritis members were ascertained from a commercial claims database (Health Intelligence Company LLC, IL, USA) using ICD9/ICD10 diagnosis codes.  Eighty two percent of HA patients did not fill opioid prescriptions postinjection, with 54% of opioid users discontinuing fills. Two-thirds of KA patients filled opioid prescriptions within 6 months postsurgery, with 78% of opioid users continuing fills and 62% of nonusers initiating use. Alternative therapies, such as HA, that reduce opioid use may alleviate opioid addiction risks for KA patients who use opioids in the pre- and postoperative periods.

Download full-text PDF

Source
http://dx.doi.org/10.2217/pmt-2020-0057DOI Listing

Publication Analysis

Top Keywords

opioid prescriptions
16
intra-articular hyaluronic
8
hyaluronic acid
8
knee osteoarthritis
8
opioid
8
opioid users
8
decrease opioid
4
opioid intra-articular
4
intra-articular corticosteroid
4
corticosteroid burden
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!